BCG therapy for bladder cancer
Publish place: 5th Congress of Medical Bacteriology
Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 556
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MBMED05_023
تاریخ نمایه سازی: 1 دی 1397
Abstract:
Background: BCG therapy is used as a treatment in bladder cancer. Methods: Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. Results and Conclution: He was treated successfully with antitubercular therapy and prednisolone.
Keywords:
Authors
Mohsen Ayati
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Reza Nowroozi
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Afshin Mortazavi
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Solmaz Ohadian Moghadam
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran